Literature DB >> 36044536

Consumer preferences, experiences, and attitudes towards telehealth: Qualitative evidence from Australia.

Kaylie Toll1, Lauren Spark1, Belinda Neo1, Richard Norman1, Sarah Elliott1,2, Leanne Wells2, Julia Nesbitt2, Isobel Frean3, Suzanne Robinson1,4.   

Abstract

In Australia, telehealth is not new, with several telehealth specialist services being available for those living in rural and remote communities. However, prior to the COVID-19 pandemic, telehealth was not routinely available for primary care or urban specialist appointments. There has been an increased focus in the use of telehealth within primary care, and particularly general practice, but overall, there has been limited research to date to guide telehealth best-practice based on consumer experiences and preferences within these settings. We aimed to capture the consumer experience of telehealth during the COVID-19 pandemic, through a novel Kitchen Table Discussion (KTD) method. This increases access to a broader community consumer cohort, with consumer hosts leading discussions in a safe environment. The KTDs were conducted in May 2021, with 10 community members each hosting a group of up to 10 participants. A total of 90 participants took part from across Australia, with the majority living in major cities, although a significant proportion lived in inner and outer regional areas of Australia, or had experience living in rural, regional or remote areas. Seventy percent of participants reported using telehealth in the past. Data were analysed sequentially using thematic analysis and identified key themes: modality, convenience, access, wait time, existing relationship, communication, connectivity, cost, and privacy. Overall, the future of telehealth looks hopeful from the perspective of the consumer, but significant improvements are required to improve consumer engagement and experience. It is evident that 'one size does not fit all', with results suggesting consumers value the availability of telehealth and having choice and flexibility to use telehealth when appropriate, but do not want to see telehealth replacing face-to-face delivery. Participants tended to agree that telehealth was not a preferred method when physical examination was required but would suit certain points of the patient journey.

Entities:  

Mesh:

Year:  2022        PMID: 36044536      PMCID: PMC9432716          DOI: 10.1371/journal.pone.0273935

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Telehealth is not new in Australia, with well-established services operating across rural and remote communities for many years. The COVID-19 pandemic has hastened the spread of digital solutions across the country and now casts telehealth into a new light [1], with its appeal of allowing health services, including general practice and allied health, to be accessed by people in their own homes. Whilst there are multiple definitions, telehealth is defined here as a method of delivering healthcare services via information and communication technologies (ICT), transmitting audio, images and data between a patient (consumer) and healthcare provider [2]. These services can be used in diagnosis, treatment, preventative and curative healthcare. Internationally, telehealth services grew exponentially in response to the COVID-19 pandemic, rapidly moving online and adapting new models of care to maintain continuity of care [3]. Despite the reported positive outcomes and experiences [4-7], many services have reverted back to similar pre-COVID levels, with spikes in usage as areas go in and out of lockdown. In Australia, a number of telehealth specialist services were available for those living in rural and remote communities, including psychiatry from 2002, specialist and consultant physician services (2011), allied mental health services (2017), and some GP services (2019), however, pre-COVID telehealth was not routinely available for primary care or urban specialist appointments. The Medicare Benefits Schedule (MBS) is a listing of items where the Australian Government will provide finanicial assistance towards the cost of public medical services [8]. Temporary MBS telehealth items were introduced in repsonse to COVID-19, to “allow people to access essential Medicare funded health services in their homes and reduce their risk of exposure to COVID-19 within the community” [9]. As at June 2021 in Australia, telehealth services now respresent 18% of all MBS items, increasing from the pre-COVID level in March 2020 of 7.9%, but well off it’s peak of 35.6% in April 2020 [10]. The modality of this telehealth usage is overwhelming via the telehone, 93% compared to 7% via videoconference [10]. A. The Australian Government has enabled provision of both phone and video consultations, with video being the preferred substitution for face-to-face when telehealth is clinically appropriate. However, uptake for phone consultation is higher and it is unknown if these usage rates are due to consumer preference or the availability given to consumers. Given the longevity of telehealth implementation, there is a substantial body of telehealth research pre-dating the COVID-19 pandemic. However, much of this work focuses on rural and remote and/or hospital settings. Since 2020, there has been an increased focus in the use of telehealth within primary care, and particularly general practice, but overall, there has been limited research to date to guide telehealth best-practice based on consumer experiences and preferences within these settings. Such information is key to informing the development of policy, sustainable funding incentives, and rigorous frameworks to ensure the quality and safety of health care delivered digitally [11]. A number of telehealth reviews have drawn on research pre-COVID, there are also publications that draw on small case studies, and a vast range of commentary and perspective pieces [3, 12–15]. Most of these publications relate to telehealth as a video consultation mode, with very limited work around telephone consultations. In addition, the majority of research and commentary is from the clinical and policy perspective, with limited focus on consumer perspectives within primary care and general practice settings, both in Australia and globally. Although descriptive and extensive across settings, the research to date particularly within the primary care setting lacks a strong evidence base, whereby benefits and concerns of consumers and clinicians have largely been perceived rather than based on strong evidence or experience. The lack of the lay input from consumers in the current literature narrows the applicability of these findings and its translation for use in general telehealth practice [11]. Studies that have focused on consumer experience and preference have tended to do so in a unidimensional way that does not capture the complexity of consumer preferences [16]. There is a need to rigorously explore consumer experiences, preferences, and attitudes towards telehealth in the primary care setting, to ensure consumer engagement and sustainability of the health system [17]. This paper aims to fill this gap in knowledge by capturing the consumer experience of telehealth during the COVID pandemic. It does this through the use of a novel method, the Kitchen Table Discussion, that can access a broader community consumer cohort and includes consumers leading discussions in a safe environment that welcomes in-depth conversation.

Methods

Kitchen table conversations have been used in various settings and contexts such as local government and political campaigns [18-21]. The Kitchen Table Discussion (KTD) methodology, pioneered first in the consumer sector by Health Consumers Queensland [22], supports the training of consumer facilitators (hosts) with a strong community network to conduct focus groups with peers. The sessions involved discussing consumer attitudes and experiences via a semi-structured focus group format. The aim of this approach is to enable informal and relaxed dialogue, so health consumers, carers and community members, who do not ordinarily participate in healthcare consultations, are able to have their say in a safe and supportive environment.

Recruiting and training the hosts

The KTD hosts were selected via purposive sampling through a widely disseminated expression of interest process coordinated by The Consumers Health Forum of Australia (CHF). Applications were assessed on the basis of a potential host’s community links and the level of diversity this could deliver in terms of KTD participants. Ten trained consumer hosts (facilitators) were selected for the role, required to identify participants through their community links and were aware that their participant group should represent diversity as far as possible. Hosts received: training via a Zoom videoconference; a comprehensive host guide; questions to ask participants during the discussion; a feedback report template; support from CHF to ensure a successful session; and appropriate remuneration in recognition of their time. This training and guidance were designed to emphasise their role as a moderator, and not a participant or responder.

Participants and recruitment

Participants were recruited by their hosts through non-probability convenience sampling with each host inviting up to 10 community members via their own local community connections, to attend either online or in-person group discussions, and to achieve a sample size allowing for a variety of experience and options to emerge. The participants were community acquaintances of the host, enabling health consumers, carers and community members who do not ordinarily participate in healthcare consultation to have their say in a safe and supportive environment. The recommendations to hosts for sampling from the host guide was as follows: “The group of people should reflect a wide diversity of ages, cultures, and health experiences. Please choose your participants mindfully, ensuring there is no conflict of interest, or you feel coerced in any way.” Due to illness one KTD host held individual consultations with participants by phone or online. Participants were required to be 18 years or older. We adopted a two-stage consent process, participants were able to consent to the study and consent to the audio recording separately. Not consenting to the recording did not exclude participants from the study. Each participant received an information sheet outlining what the project entailed, who was doing the research, how the research would be used, and who would have access to their de-identified information. Participation was voluntary, and participants could withdraw from the study at any stage. The participants were notified they would be asked to verbally answer some questions within their discussion group and provide some written basic demographic information regarding gender, age, chronic conditions, and if they had experienced telehealth previously. Participants were advised that the questions in the survey were designed not to cause any distress. If the participant felt anxious about any of the questions, they did not need to answer them. Strategies were put in place to support and assist any participants who may feel sensitive or upset after hearing some experiences of healthcare, and to please let the host know if this occurs. Participants were given a $60 gift voucher to reflect the value of their time and for participating in the study.

Conducting the focus groups

Hosts were given a step-by-step guide to run their sessions, and a feedback report template containing a set of 10 questions, plus additional question prompts (available in ). In short, participants were asked how and why they may have accessed telehealth services in the past year and discussed their experiences. Based on consumer experiences, common themes explored: The types of telehealth used across services; Circumstances where telehealth was used; The benefits of telehealth in reducing geographical isolation; The convenience of telehealth; The importance of an existing consumer-clinician relationship for satisfaction and confidence; The importance of a positive first experience with telehealth to inform future engagement; and Reasons why telehealth was not used. Each participant was given a chance to answer each question, using their own words, including real-time check back by hosts to ensure the information captured was true to the respondent. Participants were invited to make any additional comments at the end of each session or email them following the session. Hosts recorded participant responses to each question onto the template. The sessions were conducted between 10th and 28th May 2021 and lasted approximately 90 minutes each and were either recorded and transcribed, or scribed during the session. The host guide recommended to audio record each session to allow better engagement in discussion and support report template completion. Some participants did not consent to the audio recording, which did not exclude them from the study, and other groups encountered technical difficulties. The hosts completed a written report of participant responses based on a template and attached demographic data forms, participant registration sheets and completed consent forms, and sent to the research team. A member of the research team transcribed all available electronic recordings. All but one KTD session was conducted in English. Whilst we did not target non-English-speaking focus groups, in selecting KTD hosts we particularly set out to ensure diversity in terms of the potential hosts’ community links. One host had strong links to the Japanese community thus contributing to inclusion of participants from culturally and linguistically diverse communities. Because of the variability in English language proficiency of participants the KTD was undertaken in Japanese. The host translated the outcomes into English.

Data analysis

The qualitative analysis employed a combination of inductive (generating new knowledge) and deductive (testing theories) techniques [23]. All transcribed session data, report templates and demographic data forms were transferred to researchers electronically, making sure all data was de-identified. Data were analysed using thematic analysis and identified key themes. The phases of thematic analysis outlined by Braun and Clarke [24] were applied by the research team, in the six following steps: Familiarisation with the data Generation of initial codes Searching for themes Reviewing themes Defining and naming themes Producing the report. Data were analysed sequentially, for each of the 10 questions that comprised the semi-structured focus group interview template followed by the hosts. For each question, an independent researcher analysed the transcriptions and host reports through an open-coding method to generate initial codes. These codes were then applied, reviewed, and categorised into sub-themes, each then defined and labelled with a collective theme that described the core concept for each question. To ensure rigour and validity a second researcher independently reviewed the transcripts, the coding and categorisation of subthemes. Quotes are used to demonstrate findings in each theme from the voice of the participant. Each quote includes the participant allocated identification number, 1–90, location based on the Modified Monash Model and past telehealth usage. For example: P5, major city, used telehealth. Ethics approval was obtained from Curtin University Human Research Ethics Committee (HREC number HRE2021-0232).

Results

A total of 90 participants took part in the KTDs, with between 7 to 10 participants attending each KTD (mean = 9). Table 1 shows the majority of the participants were female (79%; n = 71). Most participants were aged between 35 to 54 (42%; n = 38), followed by those aged 55 to 74 (32%; n = 28), aged 18 to 34 years (18%; n = 16), with 9% (n = 8) aged over 75.
Table 1

Summary of participant demographic characteristics.

VariableParticipants (n = 90)Proportion (%)
Gender
Female7179%
Male1719%
Other22%
Age
18–25 years22%
25–34 years1416%
35–44 years1820%
45–54 years2022%
55–64 years1416%
65–74 years1416%
75–84 years78%
>84 years11%
Living with a chronic health condition
Yes4247%
No4853%
Experience using telehealth
Yes6977%
No2123%
Approximately half of participants were living with a chronic health condition (47%; n = 42). This included one group largely made up of participants with kidney disease, from those on dialysis to end-of-life care. Other groups included people from diverse backgrounds, including low socio-economic areas, Aboriginal and Torres Strait Islander communities, and non-English speaking. One group was made up of native Japanese speakers and was held in Japanese, the host translated responses into English. More than two thirds of participants reported using telehealth in the past (77%; n = 69), with nearly three quarters (69%) conducted over the phone versus videoconference (31%). A total of 10 KTDs were held across the country, in all states except for the Northern Territory and Tasmania. Most KTDs were held exclusively face-to-face (60%; n = 6), with two held exclusively via Zoom (20%), one held via a combination of face-to-face and Zoom (10%), and one held via phone and Zoom (10%). Face-to-face sessions were held in metropolitan Melbourne, Brisbane, Adelaide, Sydney and Canberra. Two face-to-face sessions were held exclusively in outer regional areas (including: Western Australia and New South Wales). Sessions held via Zoom included participants from Perth and inner regional Western Australia (South West); Brisbane and inner and outer regional Queensland (North); Canberra, Adelaide and Sydney; Melbourne and inner regional Victoria. Overall, the majority of participants were currently living in major cities, although a significant proportion lived in inner and outer regional areas of Australia, or had experience living in rural, regional or remote areas.

Modality

Telehealth consults were provided across the public, private and community services sector, with the majority conducted over the phone. The majority of phone consults were with GPs, whereas specialists and hospital-based appointments tended to use videoconference. The majority of reported consultations were with GPs. For GP consults, the primary reasons were for acute or chronic illness, questions around medications or prescription renewals, a follow-up after tests or scans, or to request for a referral to a specialist. Some telehealth consults were linked with a hospital or specialist out-patient appointment. A small number were linked to allied health (speech, occupational therapy, physiotherapy), nursing or to mental health support (psychologists, psychiatrists). Participants largely agreed that telehealth was ideal for simple, routine or non-acute situations, where a “diagnosis” is not needed. However, some participants reported being able to send photos to their clinician to support diagnosis and treatment. Participants reported that telehealth is not suited for complex or sensitive issues or where a physical examination is required. Participants reported that the lack of ability to do a physical assessment is often perceived as the inability to treat the consumer comprehensively, holistically or with a preventative focus, such that important things could be missed that may otherwise be detected face-to-face. “A biggest failure of telehealth is lack of physical assessment. Can’t check your temperature, ear canal, inside the mouth, can’t use the stethoscope to check my lungs, can’t feel skin rashes, check tooth decays, or any other physical ailments.” P39, major city, used telehealth “I did not feel like some of the services that I had were able to offer the treatment. Like psychology just does not work without eye contact for me, and particularly not when being asked to do some difficult work.” P9, major city, used telehealth Telehealth was reported as fit-for-purpose for those living with chronic conditions where telehealth provided an efficient means to maintain ongoing continuity of care for everyday issues. “Over the past year I have accessed a phone consultation with my GP and that was very simple. I just wanted a prescription renewed. That was very easy, and she had a bit of chat as to how I was, to cover a standard consultation time.” P1, major city, used telehealth When asked about their preference of choice between phone or video there was a relatively equal split between what would have been chosen, with a small number still preferring face-to-face. There were some comments that video would be preferred if needed to inspect anything visually, for hospital appointments, and generally the preference when seeing allied health practitioners. Participants noted that phone may be preferred for GPs as it is quicker and easier than video, with more flexibility and less technical requirements. A number of participants reported not being given the option between face-to-face and telehealth. One consumer mentioned they needed to request telehealth when initially only face-to-face was offered. Some participants reported perceptions that whether they were offered telehealth options or not depended on the preference of the clinician, and the decision was not consumer-led.

Themes

Participants were asked about their views on the key benefits, barriers and enablers to engaging with telehealth. Key themes include: convenience, access, wait time, existing relationship, communication, connectivity, cost, and privacy. These themes are outlined in Fig 1 and explored in detail below.
Fig 1

Illustration of the eight core themes relating to the benefits, barriers, enablers, and future improvements of telehealth.

Convenience

The main strength of telehealth was associated with the overall convenience and efficiency of telehealth, providing a less burdensome way to access quick, easy and timely health care whilst saving time, stress and money. This convenience was also associated with less risk of sharing or being exposed to contagious infections compared to face-to-face care. Participants reported that telehealth appointments were overall less burdensome, being able to remain at home with less rushing, less stress, and less need to plan and schedule attending in-person. “I think it really can’t be overstated how difficult travelling to certain appointments can be, even if they are regular standing ones. I think if you have a good relationship with your telehealth provider, then there are some services I am not keen to go to back to in person because it works just fine from my living room.” P9, major city, used telehealth “My mobility is limited by pain. My condition makes me frightened getting there… makes it difficult, parking difficulties, access, obstacles, logistics, energy resources. Telehealth is fantastic as I do not have to worry about all that.” P15, major city, used telehealth Some participants reported telehealth overall being quicker and easier than face-to-face, both from their perspective and perceived perspective of practitioners. “Definitely being able to get quick check-ins without having to wait at the medical centre, particularly for things like scripts or test results.” P46, major city, used telehealth Reduced practical logistics associated with attending a face-to-face appointment was a commonly reported advantage, particularly for those with additional needs or responsibilities. “Taking large number of kids (five kids) to a clinic is challenging for poor mothers. Especially for Aboriginal communities. There isn’t anything to entertain the kids at clinics. Kids get bored and make noise, cry and run off at times. Crèches are not available unless it’s a kid’s hospital.” P42, major city, used telehealth Saving time was the most commonly reported advantage of telehealth. It was common for participants to report overall efficiency in receiving medical care via telehealth, particularly related to time saved not having to travel or bother about traffic and parking or having to sit in waiting rooms for extended periods of time. Participants reported the advantage of being able to engage in other activities while waiting or if the practitioner was running late. “The convenience of being able to make an appointment even if I’m not able to make it physically in the office, so there are more options for when I can see the doctor if I don’t have to go there physically. Also not having to waste time sitting in a doctor’s office when the doctor is running late, I just kept going with my work while waiting for them to call–so much better!” P49, major city, used telehealth Fig 2 reports a range of situations in which telehealth was preferred as it provides more convenience and can mitigate a number of risks.
Fig 2

Participant views on convenience and risk reduction associated with telehealth consultations.

Access

Increased access to care was seen as a common advantage of telehealth, particularly in relation to accessing rapid medical attention with an efficient exchange of information. This was experienced across both acute care (e.g., emergency telehealth) and primary care (e.g., GPs). Participants reported telehealth has enabled them to access medical care or services that they would otherwise not have available or would otherwise be less likely to engage in should they need to attend face-to-face. This is particularly true for those living in rural and remote communities, particularly when they may only have typical access to visiting locums or specialists based in metropolitan areas or interstate. “Telehealth is just so convenient and has improved my access to services that I may otherwise have neglected or have been difficult for me to access.” P51, major city, used telehealth Increased access and reduced costs were reported to be a benefit for those living in regional or remote areas. Living in more isolated areas also increased reliance on videoconferencing capabilities where they may be limited phone reception. Participants also reported the flexibility of arranging and attending a telehealth appointment, with an increased scope of availability/appointment times to access medical care in a timely manner. Participants reported that telehealth should be used to support multidisciplinary approaches to healthcare, providing a more integrated and consumer-focused service. Access should be offered via both video and phone, with consumers empowered to choose their preference. Participants reported that telehealth should be available 24/7 and should be extended beyond GPs and hospitals and further into primary care (e.g., mental health and dietetic services). “Preference comes into it, but I do not want to go back to a world without accessing telehealth. I think for most people it has been good to have that option.” P9, major city, used telehealth Participants suggested that telehealth needs to be more accessible to a wider range of people. Participants suggested that engagement and research should explore how telehealth can be maximised among targeted and vulnerable groups, including youth, elderly, homeless, those with a disability, those with a mental health illness, carers, those with a low socio-economic status, and Indigenous communities. Participants suggested that interpreter services need to be embedded within telehealth, easily and widely accessible to support the Culturally and Linguistically Diverse (CALD) community. Some participants who spoke English as a second language reported discomfort when conversing over the phone and felt telehealth exacerbated communication issues. To compensate for language limitations, these participants reported often relying on visual information (such as viewing of test results), but the lack of this kind of visual informational aid when using the telephone contributed to a reduction in the level of understanding. Video consultations may help to improve these situations, but some participants reported face-to-face contact was still preferred for optimal communication. One suggestion is to explore how telehealth could be used to link consumers to practitioners that speak their language. It is also important to focus attention on how telehealth could be maximised within urban areas, not just rural and remote. “I think it is great. I’d like to see more telehealth because, as you said, it is better for regional people, people with disabilities, maybe some people who are not comfortable face-to-face. Maybe this is more comfortable for them. The government needs to look more into this, so we don’t have these issues with communicating…” P5, major city, never used telehealth Some participants raised concerns over digital literacy and what support patients would have with technology issues. “These days people are expected to use a digital device to do everything. However, it is unclear which government division is responsible to support those with limited IT literacy and don’t have a family member to assist them.” P64, major city, never used telehealth

Wait-time

Participants reported the flexibility of arranging and attending a telehealth appointment, with an increased scope of availability and appointment times to access medical care in a timely manner. The flexibility and increased access of a telehealth appointment compared to face-to-face was associated with the ability to seek medical attention more rapidly. “I was able to wait for the appointment in the comfort of my home, rather than a waiting room and didn’t have to travel when feeling really unwell or try and find someone to take me.” P53, major city, used telehealth However, some participants suggested that telehealth was associated with longer wait times, and an overall lack of efficient systems and processes. This was particularly a deterrent when practitioners were running late and there was poor communication to consumers to advise of the delay. Some participants reported being given a window of a few hours in which their telehealth appointment would be conducted, with others agreeing they often waited for long periods for their appointment to start, unsure if they had been forgotten. “And on the few occasions I’ve used it, one occasion they were extremely late, one occasion they were 15 minutes late and a couple of times they were just about bang on time. So you just have to juggle your time and wait for it unfortunately and that is a weakness.” P19, inner regional, used telehealth The lack of perceived respect for consumers’ time reflected by practitioners’ timely attendance to telehealth consults was a concern for participants. Overall, while it may be easier and quicker to access care via telehealth, the perceived quality of care of telehealth may be impacted by long waiting times and the inefficiency of current communication systems and processes.

Existing relationship

When discussing appropriateness and quality, participants noted the importance of having existing relationships with a trusted and familiar clinician. Participants reported increased confidence, trust and comfort when using telehealth with a regular clinician who was familiar with them and their medical history. There were concerns or hesitations in having a telehealth consult with a new practitioner, reporting either experienced or perceived difficulty forming a trusted relationship and subsequently questioning whether the medical advice provided via telehealth could be trusted. “At the time I wasn’t visiting my local GP practice and so I was concerned that I would just get any other doctor and they wouldn’t know my medical history or anything like that. I know they would provide, you know, the sort of same level of care but I think it’s just familiarity with your doctor and already having that established doctor-patient relationship.” P56, outer regional, used telehealth Whilst there were concerns that something may be ‘missed’ via telehealth, even with a familiar practitioner, the presence of a trusted existing relationship may be a protective factor in alleviating such concerns. “I do not necessarily trust the online diagnosis; I would like to have met the doctor in person in advance.” P13, major city, used telehealth “…I chose to see the doctor in person. I usually see the doctor in person to develop rapport and relationship. I wouldn’t trust it over telehealth. I won’t be able to open up.” P74, inner regional, never used telehealth

Communication

Overall, poor communication was a commonly reported telehealth weakness, particularly how care delivered virtually may be less engaging or impersonal, and contribute to a lack of confidence and trust in the advice provided via telehealth. Participants identified the importance in the interpersonal and communication skills of the clinician to ask the right questions, in the right tone, with appropriate verbal and non-verbal cues such that consumers feel comfortable and that clinicians are attentive. “Medical providers also need to be trained so that the best experience can be enjoyed, with good outcomes. Not just video conferencing protocols and etiquette, but acquiring suitable equipment, for example, cameras that can angle to see injuries or wounds, zoom in and out, large enough screens so providers can see patients’ body language, physical condition.” P86, outer regional, used telehealth Participants also reported the importance of telehealth consults not being rushed, there needs to be enough time and good communication between consumer and practitioner to exchange information freely, with adequate opportunity for consumers to ask questions. Practitioners also need to have the ability and time to access historical medical records for consumers to feel confident, comfortable and adequately cared for. “I think that doctors tend to prioritise in-person appointments and fit the telehealth ones in around that—they don’t seem to respect the validity of phone appointments as much and often seem to call you much later than your appointment which then isn’t always a convenient time. I had one doctor call me a couple of hours after my appointment and I was in Coles [supermarket] doing the shopping with my kids and he just started talking to me about my test results without checking if it was a good time to talk.” P50, major city, used telehealth Good communication, access to adequate medical records, and the ability to ask questions were important factors contributing to whether telehealth provides value for money. Participants noted that a weakness of telehealth is the loss of interpersonal connection and how this could impact on the quality of care. “I think that having that interpersonal connection when you are using body language and you are modulating your tone of voice to the person physically in the space with you, makes a big difference. So that is a general weakness that I feel.” P9, major city, used telehealth

Connectivity

Connectivity and accessibility to telehealth were key barriers, such that poor technical quality greatly influenced the experience, satisfaction and quality of care provided via telehealth. Issues with poor audio, visual and connection quality were commonly reported, particularly for videoconferencing. “I was on a phone call telehealth the other day and because the reception in this area of (placename) is awful, just really awful, my phone call dropped five times over an hour and I had no way of being able to contact the provider back because it was a private line. So each time it would drop out, I had to wait for them to call back. It was just atrocious.” P9, major city, used telehealth “You lose your conversation, you get frustrated. One of you will hang up and then you’ve got to go back through the rigmarole of getting another appointment. OK if it’s only something minor like you’ve broken your arm and you go to the hospital, fine. But if you’ve got something major, like you’re having a heart attack or you’ve popped your eye out or something really serious, telehealth’s not going to help you.” P18, inner regional, never used telehealth Participants were particularly concerned that telehealth may be rolled out on a larger scale as standardised care before adequate investment in quality and stability of services; quality should be setting the pace, not the technology. Enhancing the quality of virtual interactions through embedding reliable technology and increasing connectivity may improve the consumer experience and value of telehealth, particularly in rural and remote areas. “The hospital it was “clunky” never worked most of the time. So, 50% of the time we used telephones (they were meant to be via video). Video consult offers best value and next to face to face consults, so I was bummed when the video didn’t work. They would call me, and we have problem with video and going to call via telephone.” P73, major city, used telehealth

Cost

Participants agreed telehealth was beneficial in terms of reduced costs related to travel, parking, accommodation, and time compared to a face-to-face, especially for those living in regional and remote areas. Participants were asked if they would be willing to pay the same amount or more for a telehealth consultation as a face-to-face consultation. The majority of participants agreed that telehealth should either be the same or less than a face-to-face consultation. The value for money of telehealth is perceived as lesser than face-to-face, largely because of shorter consultation times, the inability to be assessed comprehensively, and the impersonal nature of a virtual consult contributing to a sense of lower satisfaction in the quality of care provided. “Most telehealth appointments are very short, such as less than 5–10 minutes. A telehealth appointment never takes as long as 15–20 minutes. Hence, paying the same price as for a face-to face-consultation is unfair. Lack of physical assessment means the paying the same amount is unfair.” P37, major city, used telehealth “I was charged the same fee as the face-to-face consult, which I am not about, because the doctor did not do any physical assessment and I didn’t feel that I received the same quality of care as a face-to-face consult.” P76, major city, used telehealth Some participants may be happy to pay more for the convenience that telehealth affords, although overall there was agreement that telehealth should be fully covered by the public sector MBS or costs at least standardised. “I would pay the same but it depends on the situation. If it was urgent and got me medical care that was otherwise unavailable, then I may be happy to pay more. If it was for a minor issue I would expect to pay less.” P32, inner regional, never used telehealth “It was very convenient to speak to doctor on phone to organise referral to appropriate specialist. Also had time in consult to talk about vaccination and other issue. Another telehealth service provided a convenient way to get a diagnosis of a simple condition that had re-occurred. Each telehealth appointment was bulk-billed which made it cheaper than a normal appointment.” P27, major city, used telehealth

Privacy

During the discussions we also asked participants two questions relating to privacy and disclosure: Concerns about the privacy of telehealth; and, If clinicians have ever discussed privacy issues with them. A large proportion of participants reported privacy not being an issue. These participants had a standard expectation that health professionals would operate within ethical and professional boundaries. “Not really any concerns as I trust it is as private as a face-to-face consult.” P45, major city, used telehealth Where participants did have concerns, this was primarily related to being unsure who was in the room or could overhear the conversation (from both the consumer and health professional side), and general cyber security and data protection concerns, including hackers. The majority of participants indicated that privacy had never been explicitly discussed between clinician and consumer. Of those that did recall a discussion, this was normally done at the beginning of a session, if another person was in the room, or general privacy information was provided via a letter or email. Communication generally identified that the same privacy and confidentiality standards that applied to face-to-face applied to telehealth. A number of participants reported they assumed privacy standards would be upheld, that there were no differences when compared to face-to-face, and that they expected the clinician to advise if otherwise or if any concerns. “The doctor was really good and before we started asked if I had a private, comfortable place to chat before we started and she reassured me that she was in her office and it was private and asked me if I had any questions before the consult began–it may be because she knows I live in a share household, but she was great and I wish all my doctors and health professionals took that kind of care.” P48, major city, used telehealth

Discussion

Overall, the future of telehealth looks hopeful from the perspective of the consumer, but significant improvements are required to improve consumer engagement and experience. Whilst telehealth is a simple modem of communication (technology) it operates in a complex service delivery model, both on the demand and supply sides. Going forward it is important to understand this complexity (which is dynamic and emergent), when implementing telehealth technology into health systems [25]. Results from our study suggest that consumers do not want to see telehealth completely replacing face-to-face consultations, but do value the availability of telehealth and having choice and flexibility to use telehealth when it’s appropriate for them. Other studies had reported that the convenience of telehealth mostly outweighed concerns about lack of physical examination when the interaction was generally routine and there was an existing relationship with the provider [5, 6]. Thus, telehealth does have a place in the health system in both primary and secondary care settings, but this needs to be considered in relation to patient-centred health and the care journey as the patient transitions across the continuum of care. Deciding when telehealth is appropriate across the patient journey is difficult given the complex and multi-dimensional nature of consumer preferences and behaviours [16]. Our research does uncover some interesting insights that go some way towards helping to understand telehealth’s place across the health system. Firstly, it is evident that . For example, we have participants who reported that not having to present for a face-to-face consultation was advantageous whilst others suggest that they prefer face-to-face consultations. Participants tended to agree that telehealth was not a preferred method when physical examination was required. The lack of ability to do a physical assessment is often perceived as the inability to treat the consumer comprehensively, holistically or with a preventative focus, such that important things could be missed that may otherwise be detected face-to-face. Other studies note that physical examination was seen as an important challenge [5, 6, 26], with some consumers’ perception being that without the opportunity to undertake a physical examination, the quality of care would be impacted. When discussing appropriateness and quality, participants noted the importance of having existing relationships with a trusted and familiar clinician. Like other studies our respondents identified that established patient-practitioner relationship through prior face-to-face contact is important for effective telehealth consults [26]. Like all types of consultations, participants judged success in terms of how well they felt listened to, the manner and behaviour of the clinician, and the clinician’s knowledge around their medical history and condition. Other previously published studies also suggest that those who had an established relationship prior to using telehealth felt more comfortable during the conversation [27]. Gordon et al [6] and Holmström et al [28] both reported that the inability of patients to see their health care provider in person affected the opportunity to engage and build a relationship, also more prominent in telephone consultations where the provider can be heard but not seen [29]. The notion of existing relationships relates to the continuity aspects of good primary care which is important across time, settings, conditions and people. The recent Australian Primary Health Reform Steering Group [30] suggest that primary health should be the lynchpin for continuity of care across all stages of life. Our findings suggest that telehealth incorporated into an effective model of primary care could support this. For example, participants noted that telehealth was appropriate for some routine consultations such as repeat prescriptions, referral or follow up appointments and for some minor acute issues. Telehealth’s convenience and its ability to support accessibility for patients to visit their preferred GP, can support continuity and better self-care management of chronic conditions, with shorter, more frequent telehealth visits, for example supporting in medicine management or reassuring and coaching patients around self-care. Noting there may be need for allowances to the ‘usual medical practitioner’ rule, where consumers prefer to maintain privacy from a regular or family GP. The increased scope of availability and appointment times allows for the accessing of medical care in a timely manner. Addressing issues early and within primary care could increase the focus on ‘right care, right time, right place’. Study participants suggested that telehealth was not appropriate for more complex or sensitive issues or where a physical examination is required. Similarly, there was mixed opinion regarding mental health consults, with some preferring face-to-face for more severe cases and eye contact, but others preferring telehealth due to the ease of access. The above highlights the appropriateness of telehealth at certain points of the patient journey. For example, for patients with a chronic condition there are instances along the patient journey that are more suited to telehealth than others. These would include telehealth use in monitoring and ‘checking in’ with patients, providing medication review, repeat prescriptions or test results, but less appropriate when the patient needs to be examined or have discussions around diagnosis and management of the condition, particularly during the onset of disease. Other studies also noted the convenience of telehealth as a major advantage with respondents noting how having consults through telehealth allowed them to fit consults around ‘their day’ rather than the providers’ day [5]. Donaghy et al [31] reported that the convenience of telehealth is particularly noted for those “who commute to work and for those who have lives structured around work, study, or childcare”, and/or live remotely with individuals not needing to book leave from work or pay additional travel costs. Both studies reported that the time reduction had a positive impact in reducing stress and anxiety [5, 31]. It is also worth noting the differences in consumer preferences in regional Australia compared to those in urban and metropolitan areas, with access to primary care and general practice often being more difficult in the former. Telehealth reduces typical barriers to accessing care, particularly related to the practical logistics of attending a face-to-face appointment. Telehealth provides means of increased access and engagement amongst geographically isolated consumers and its implementation could well be different in rural and remote communities. Whilst face-to-face is often the preferred service, if that is not easily available then telehealth provides a real alternative. If implemented well it could support increased access to primary care for these in regional Australia which are home to some of our most vulnerable communities. An area of importance highlighted in the literature is that of disadvantaged and minority groups. This study had some representation from CALD and Aboriginal and Torres Strait Islander people. There was some indication that for these groups, accessing care via telehealth can remove some of the stigma and discomfort consumers may experience attending face-to-face appointments, particularly among vulnerable groups. Some consumers reported that not having the stress of travel and sitting in the waiting room was a positive experience for them.

Technology and connectivity

There are a number of technological aspects that can be challenging for telehealth delivery and uptake in Australia. It goes without saying, that if a patient cannot access the internet or telephone services, then they are not practically able to utilise telehealth services. There is limited consistency in the platforms used and participants suggested the current platforms are “clunky”, with common experiences in servers, platforms and websites being down. Communication systems are sub-optimal, particularly if sessions are running behind, with participants often left waiting for a long time for their appointment to start, unsure if they have been forgotten. Living in more isolated areas also increased reliance on videoconferencing capabilities where they may be limited phone reception. For some individuals telephone has been preferred due to the lack of access and/or knowledge and competence in using video platforms. There is some evidence to say that this is more pronounced for some groups, including older people and people with disabilities [32-34]. This highlights the importance of digital literacy and supporting consumers in increasing their digital literacy skill so there is not inequity in relation to the access and use of telehealth technology.

Limitations

Whilst this study and its findings provide areas worthy of consideration, the study limitations should be noted. The majority of participants were female (79%), thus there is an underrepresentation of males in the study sample. Bias may be present in the method of convenience sampling and may not be representative of the population. Given the importance of ensuring access and equity to vulnerable groups the lack of representation of CALD and Aboriginal and Torres Strait Islander people within the KTD needs to be addressed in future research. In addition, the study only focused on only one side of the coin and further research that explores clinician’s perspectives especially those in primary care (including Allied Health) is important in shaping our understanding of the implementation of telehealth in primary care and the broader health system. A further limitation was the reliance on Hosts to take notes during some sessions when audio recording was not an option.

Conclusion

The findings reflect the consumer experience of telehealth at a unique point in time where the COVID-19 pandemic had accelerated its public financing and utilisation. Nonetheless, with the pandemic serving as a catalyst to considering how telehealth should be embedded and sustained in healthcare, the findings are instructive. As the pandemic persists, policy makers have several considerations if the community is to see telehealth services continue. Continuation needs to occur in a manner that avoids low value for money, and that provide high value technologies and experiences of care. The KTD methodology resulted in several key themes, but also made it clear there was not a ‘one size fits all’ solution. What also remains unclear is the complexity of these consumer preferences in relation to telehealth or face-to-face consults across the spectrum of virtual care services. For example, if virtual care services required a smaller out of pocket cost, would they become a more attractive option? Or would virtual care become an attractive option if it prevents significant travel, and can be conducted with a doctor that the patient knows?

Policy, practice and research implications

Policy and practice implications must be considered in terms of both the direction of travel in health care, that is, consumer expectations of personalised medicine, integrated care and care close to home, as well as the available policy ‘levers’ through which change can be achieved. Work needs to be undertaken in the implementation of telehealth and the normalisation of telehealth mode of delivery into the patient journey. Telehealth services should not be full substitutes for face-to-face care, and ideally linked to provision by a provider with a prior relationship with the patient. Exceptional circumstances where it is not possible for patients to have an existing relationship with a particular provider should be catered for to ensure equity of access. For example, 24 temporary MBS telehealth items were introduced in July 2021 for sexual, reproductive health and blood borne viruses which are exempt from the ‘usual medical practitioner’ rule, allowing greater confidentiality for the consumer [8]. Enhancing the quality of virtual interactions, embedding reliable platforms and technology, and meeting the access and equity needs of vulnerable and targeted groups will go a long way in boosting the confidence consumers have to engage and trust telehealth services. Telehealth has the potential to support with routine management for those with chronic conditions, but the complexity of the consumer and health services needs to be considered when developing service models. Whilst telehealth provides an opportunity to empower patients and promote consumer choice, the quality of the consult (telehealth or otherwise) can influence consumer satisfaction and perceived effectiveness. Participants noted the lack of video conference options being offered by general practice and that availability tended to be driven by health professionals rather than consumers. Other studies also highlighted that the availability and modalities of telehealth are often provider driven rather than consumer led [35]. Consumer and patient involvement in the design, delivery and evaluation of telehealth services is crucial to success. Ultimately, consumers should be empowered to choose why, when, where and how they use telehealth services and as such the approach of ‘nothing about me without me’ should be incorporated into future telehealth policy, practice and research.

KTD questions for consumers.

(PDF) Click here for additional data file. 16 May 2022
PONE-D-22-09068
Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia.
PLOS ONE Dear Dr. Toll, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 30 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Simone Borsci, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following financial disclosure: “This research was supported by the Australian Government Department of Health and the Digital Health CRC Limited (DHCRC). DHCRC is funded under the Commonwealth’s Cooperative Research Centres (CRC) Program.” Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This research was supported by the Australian Government Department of Health and the Digital Health CRC Limited (DHCRC). DHCRC is funded under the Commonwealth’s Cooperative Research Centres (CRC) Program.” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This research was supported by the Australian Government Department of Health and the Digital Health CRC Limited (DHCRC). DHCRC is funded under the Commonwealth’s Cooperative Research Centres (CRC) Program.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. Additional Editor Comments : Dear Authors, the comments of the Reviewers are overall positive. Nevertheless, one of the reviewers provided a list of critical points that need to be adjusted to ensure the replicability of the study. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. The inclusion of minority groups in this study is key a strength. Could you elaborate if conducting a focus group in a language other than English was intended? 2. What were the experiences of the CALD group in accessing telehealth and were there barriers due to language? Could you elaborate on whether telehealth was conducted with clinicians that spoke the same language as participants or with interpreters or caregivers? 3. It is noted that face-to-face consultations were preferred by participants when physical examinations were required. Was there any evidence of physical examinations being conducted via videoconference? Did participants find this of value and did they feel prepared and comfortable to undertake this in their homes? 4. Is it worth commenting on the under representation of men as a study limitation? 5. Minor typographical errors for review. Line 66: 'response' spelt incorrectly. Lines 72-76: sentence is difficult to read and would be helped if simplified? Line 167: missing 'to' after responses? Lines 211-213: colon after Sydney should be a semicolon or comma? Line 227: missing closed bracket after physiotherapy? Reviewer #2: Thank you for asking me to review this manuscript. I would firstly like to congratulate the authors on an interesting and timely study. Given the proliferation of telehealth, capturing the consumer experience of telehealth during the COVID pandemic, is indeed a useful exercise. I do have some suggestions for further improvement of the manuscript: • Research methodology - Within qualitative, there are number of methodologies (grounded theory, phenomenology, ethnography etc). What is the qualitative methodology for this study? • Kitchen Table Discussion – I have not heard of this before but sounds very interesting. Why was this chosen as the method of data collection? Has this been tried before in other similar research? • Sampling – How were the participants identified and recruited? There is no reference in this section. Sampling framework needs more details and references. • Recruitment – There are two groups here from what I understand. There are the “hosts” and “participants”. It would be good to break the recruitment strategies into these two groups and report it as such. For example, how did the hosts source the contact details of the participants? How did the researchers ensure there was enough coverage of participants? If the host and participants were social acquaintances, how was coercion avoided? • Data collection – So the hosts recorded participant responses each question onto template and then it was audiorecorded and transcribed? Is that right? If so, why did you collect the same data in two different ways? • Who did the transcription of the interviews? • How was observation data managed? • Rigour –It would be useful to outline clearly the strategies used and how this contributed to the rigour of the data collection and analysis. This is not clearly articulated. • Data collection –Was there any follow up to clarify any issues? How did member checking actually occur? Again, there needs to be references here to defend your choice. • Sample size – how was sample size determined? • Sometimes you use the word “interview” and sometimes it is focus group. Please be consistent. • How did you ensure rigour and trustworthiness? • “The interviews opened by asking respondents about the modality of telehealth services and which if any services are preferred for telehealth” – this is Method right? Not results. • “Telehealth consults were provided across the public, private and community services sector, with the majority conducted over the phone.” – where is the data to back this up in text? • For each quote, it is important to provide some information about the person who reported it. You could include a pseudonym or other characteristic as it would add weight to your results and show the reader who said what. • Need a section on limitations. • Implications for practice and research – Based on the findings from this research, what are the implications for practice and research? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 29 Jun 2022 Dear the Editor and Reviewers, We, the authors, would like to thank both the Editor and Reviewers for the time taken to thoroughly review and provide feedback to our manuscript. We have found this to be incredibly useful and enabled the manuscript to be developed into a more precise and well-thought through version. Thank you for the opportunity to make these revisions to our manuscript and resubmit a version that addresses each of the points raised during the review process. The table in the attached "Response to Reviewers" letter shows each point raised by the Editor and each Reviewer, and how we have responded to each point. The line numbers stated are for the marked-up copy of the manuscript, so will differ to the unmarked version. Thank you again for the invaluable feedback and time given, and for considering our manuscript for the PLOS ONE journal. Yours sincerely, Kaylie Toll On behalf of the authorship team Submitted filename: Response to Reviewers.docx Click here for additional data file. 14 Jul 2022
PONE-D-22-09068R1
Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia.
PLOS ONE Dear Dr. Toll, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mukhtiar Baig, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #3: The authors have not made all data available (but have explained the reasons for this adequately). I felt the manuscript was well written and in the main, the previous reviewer comments had been dealt with adequately. Having not seen the manuscript prior to its resubmission following responses to peer review, I have not conducted a full, fresh review, but restrict my comments to the extent to which I feel that previous reviewer comments have been dealt with. I suggest some further minor amendments. 1. Reviewer 2 noted the possibility of coercion if participants were previously known to hosts or were social acquaintances. The authors did not address this point in their response but it is an important one that has bearing on the rigour, reproducibility and credibility of the data, so I would ask that the authors include a specific comment within their methodology on this. It is likely that most of the participants knew the hosts because the hosts took the lead on sampling and recruiting participants from within their networks. Allied to this - what influence (if any) did the researchers have on the diversity of participants that the hosts recruited e.g. was there a sampling frame that hosts were required to use, or did they have complete carte blanche over who they recruited to be in the KTD? 2. It is not clear why the issues with data recording arose in the first place. Usually, if a participant does not consent to being recorded, they are in essence not consenting to the study and ought to take no further part in it. It is strange that the authors chose instead to not record the entire session simply because one individual may not have wanted to be recorded. This may have implications for the quality of data from the sessions that were not recorded, and I would like to see more reflection on this approach (and its potential consequences) in the paper. 3. Whilst the authors have addressed a point about the data analysis process from the perspective of dual coding from a second researcher, the authors did not address the important point from reviewer 2 about member checking e.g. were hosts and/or participants given the transcripts so that they had the opportunity to amend anything they said or withdraw any of their statements? If not, why not? Similarly, rigour and trustworthiness can be broader than simply having dual review of transcripts/coding (reviewer 2 point 12). I would invite the authors to consider how they ensured rigour/trustworthiness in a broader sense than just in the data analysis stage. 4. The authors chose not to add any information about the person saying a quotation because of the possibility of anonymity being broken. This is a legitimate concern but would actually not preclude the authors adding some very brief information on an individual that would not break participant confidentiality, such as gender, broad age (e.g. under 50, above 50), some sense of urbanity/rurality (given that this is one of the characteristics the authors surmise may make a difference to patient receptiveness to telehealth), or past use of telehealth yes/no. I would maintain that having some information about the person who reported a quotation is still very important, and can be done sensitively without any risk that a participant would be identified from the manuscript. I would ask the authors to reconsider their decision on this point. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
16 Aug 2022 Dear the Editor and Reviewers, We, the authors, would like to thank both the Editor and Reviewers for the time taken to review our previous responses and provide feedback to our manuscript. We have found this to be incredibly useful and enabled the manuscript to be developed into a more precise and well-thought through version. Thank you for the opportunity to make these revisions to our manuscript and resubmit a version that addresses each of the points raised during the review process. The table below shows each point raised by the Editor and each Reviewer, and how we have responded to each point. The line numbers stated are for the tracked changes copy of the manuscript, so will differ to the unmarked version. Thank you again for the invaluable feedback and time given, and for considering our manuscript for the PLOS ONE journal. Yours sincerely, Kaylie Toll On behalf of the authorship team Submitted filename: Response to Reviewers.docx Click here for additional data file. 18 Aug 2022 Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia. PONE-D-22-09068R2 Dear Dr. Toll, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mukhtiar Baig, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): No comments Reviewers' comments: 22 Aug 2022 PONE-D-22-09068R2 Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia. Dear Dr. Toll: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Mukhtiar Baig Academic Editor PLOS ONE
  23 in total

1.  "I'm Not Feeling Like I'm Part of the Conversation" Patients' Perspectives on Communicating in Clinical Video Telehealth Visits.

Authors:  Howard S Gordon; Pooja Solanki; Barbara G Bokhour; Ravi K Gopal
Journal:  J Gen Intern Med       Date:  2020-02-03       Impact factor: 5.128

2.  Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies.

Authors:  Trisha Greenhalgh; Joseph Wherton; Chrysanthi Papoutsi; Jennifer Lynch; Gemma Hughes; Christine A'Court; Susan Hinder; Nick Fahy; Rob Procter; Sara Shaw
Journal:  J Med Internet Res       Date:  2017-11-01       Impact factor: 5.428

3.  The Bright Elusive Butterfly of Value in Health Technology Development Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".

Authors:  Trisha Greenhalgh; Nick Fahy; Sara Shaw
Journal:  Int J Health Policy Manag       Date:  2018-01-01

Review 4.  Internet videoconferencing for patient-clinician consultations in long-term conditions: A review of reviews and applications in line with guidelines and recommendations.

Authors:  Agnieszka Ignatowicz; Helen Atherton; Celia Janine Bernstein; Carol Bryce; Rachel Court; Jackie Sturt; Frances Griffiths
Journal:  Digit Health       Date:  2019-04-23

5.  Acceptability, benefits, and challenges of video consulting: a qualitative study in primary care.

Authors:  Eddie Donaghy; Helen Atherton; Victoria Hammersley; Hannah McNeilly; Annemieke Bikker; Lucy Robbins; John Campbell; Brian McKinstry
Journal:  Br J Gen Pract       Date:  2019-08-29       Impact factor: 5.386

Review 6.  Barriers and Facilitators That Influence Telemedicine-Based, Real-Time, Online Consultation at Patients' Homes: Systematic Literature Review.

Authors:  Hassan Khader Y Almathami; Khin Than Win; Elena Vlahu-Gjorgievska
Journal:  J Med Internet Res       Date:  2020-02-20       Impact factor: 5.428

7.  Telehealth consultations in general practice during a pandemic lockdown: survey and interviews on patient experiences and preferences.

Authors:  Fiona Imlach; Eileen McKinlay; Lesley Middleton; Jonathan Kennedy; Megan Pledger; Lynne Russell; Marianna Churchward; Jacqueline Cumming; Karen McBride-Henry
Journal:  BMC Fam Pract       Date:  2020-12-13       Impact factor: 2.497

Review 8.  Can you hear me now?: Improving palliative care access through telehealth.

Authors:  Kristen Allen Watts; Emily Malone; J Nicholas Dionne-Odom; Susan McCammon; Erin Currie; Jennifer Hicks; Rodney O Tucker; Eric Wallace; Ronit Elk; Marie Bakitas
Journal:  Res Nurs Health       Date:  2021-01-04       Impact factor: 2.228

9.  Opportunities and challenges for telehealth within, and beyond, a pandemic.

Authors:  Ann Blandford; Janet Wesson; René Amalberti; Raed AlHazme; Ragad Allwihan
Journal:  Lancet Glob Health       Date:  2020-08-10       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.